Background: Genome-wide association studies (GWASs) have identified a large number of single-nucleotide polymorphisms (SNPs) associated with narcolepsy. However, the sum impact of these SNPs on defining the genomic risk of narcolepsy remains unknown. In the present study, we investigated the associations between genetic risk scores (GRSs) and narcolepsy along with their predictive power.
Methods: A case-control study consisting of 903 narcolepsy patients and 1,981 healthy control subjects was performed. Thirty-two SNPs previously reported to confer susceptibility to narcolepsy were assessed for their association with narcolepsy risk. Subsequently, we constructed four GRS groups comprising reported narcolepsy susceptibility SNPs located in different genomic regions, and tested their association with narcolepsy risk using a regression model. Receiver operating characteristic (ROC) curves were used to examine the discriminatory power of the GRSs for predicting narcolepsy.
Results: Nine individual SNPs were significantly associated with narcolepsy after Bonferroni correction. All four GRSs were strongly associated with narcolepsy risk even when GRSs were constructed using SNPs located outside the previously implicated human leukocyte antigen (HLA) region on chromosome 6. The odds ratio (OR) for narcolepsy risk increased with the number of genetic loci implicated, ranging from an OR of 2.016 (95% CI, 1.657-2.456) to an OR of 4.298 (95% CI, 3.378-5.481). GRS4, constructed using the narcolepsy-associated SNPs identified in the Chinese population, was most closely associated with narcolepsy risk.
Conclusions: The results suggest that the GRS method for combining common genetic variations can significantly associate GRS scores with narcolepsy risk and may facilitate narcolepsy risk stratification for prevention trials, both for HLA-DQB1*06:02-positive and -negative individuals.
Keywords: Case-control study; genetic risk score (GRS); single-nucleotide polymorphisms (SNPs).
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Differences in clinical and genetic characteristics between early- and late-onset narcolepsy in a Han Chinese cohort.Neural Regen Res. 2020 Oct;15(10):1887-1893. doi: 10.4103/1673-5374.280322. Neural Regen Res. 2020. PMID: 32246636
The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci.PLoS One. 2017 Jun 15;12(6):e0179348. doi: 10.1371/journal.pone.0179348. eCollection 2017. PLoS One. 2017. PMID: 28617847 Free PMC article. Clinical Trial.
DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.Sleep. 2014 Jan 1;37(1):19-25. doi: 10.5665/sleep.3300. Sleep. 2014. PMID: 24381371 Free PMC article.
Assessing the clinical utility of a genetic risk score constructed using 49 susceptibility alleles for type 2 diabetes in a Japanese population.J Clin Endocrinol Metab. 2013 Oct;98(10):E1667-73. doi: 10.1210/jc.2013-1642. Epub 2013 Aug 16. J Clin Endocrinol Metab. 2013. PMID: 23956346
Aggregate Effects of Intraocular Pressure and Cup-to-Disc Ratio Genetic Variants on Glaucoma in a Multiethnic Asian Population.Ophthalmology. 2015 Jun;122(6):1149-57. doi: 10.1016/j.ophtha.2015.01.024. Epub 2015 Mar 4. Ophthalmology. 2015. PMID: 25745874